Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.321
+0.115 (55.98%)
At close: Jun 26, 2026, 4:00 PM EDT
0.294
-0.027 (-8.44%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or -29.41% compared to the previous year.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$294,292
Profits / Employee
-$881,875
Market Cap
12.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| MetaVia | 8 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
| Cadrenal Therapeutics | 5 |
| Kairos Pharma | 4 |
CRIS News
- 10 hours ago - Curis announces eleven active clinical sites in TakeAim CLL study - TheFly
- 10 hours ago - Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split - PRNewsWire
- 1 day ago - Curis Transcript: EGM 2026 - Transcripts
- 21 days ago - Curis Proxy statement: Proxy filing - Filings
- 21 days ago - Curis Slides: Corporate presentation - Filings
- 5 weeks ago - Curis Proxy statement: Proxy filing - Filings
- 5 weeks ago - Curis Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Curis reports Q1 EPS ($1.25), consensus (29c) - TheFly